UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047476
Receipt number R000054144
Scientific Title Additional acquisition of healthy subjects in the previous study "Longitudinal Observational Study of Atypical Pain in the Oral-Facial Region by Brain Imaging Analysis".
Date of disclosure of the study information 2022/04/13
Last modified on 2023/08/23 13:32:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Additional acquisition of healthy subjects in the previous study "Longitudinal Observational Study of Atypical Pain in the Oral-Facial Region by Brain Imaging Analysis" (July 1, 2017 - July 31, 2021).

Acronym

Additional acquisition of healthy subjects in the previous study.

Scientific Title

Additional acquisition of healthy subjects in the previous study "Longitudinal Observational Study of Atypical Pain in the Oral-Facial Region by Brain Imaging Analysis".

Scientific Title:Acronym

Additional acquisition of healthy subjects.

Region

Japan


Condition

Condition

healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Subjects in this study were 40 healthy adults (matched for age and gender with 24 patients with Atypical Odontalgia (AO) enrolled in a previous study (UMIN000029226). The subjects will be enrolled to schedule two imaging measurements in the first and second brain imaging time periods matched with those of the AO patients in the previous study (mean: 222 days).

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Head Magnetic Resonance Imaging data

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Must be 20 years of age or older and in good health (no medical conditions requiring treatment are indicated in the medical examination).
2 Be able to tolerate relatively loud noise (noise during MRI imaging).

Key exclusion criteria

1) Patients with serious systemic complications such as heart failure, renal failure, liver failure, and respiratory failure
2) Patients with severe psychosis or psychiatric symptoms that make it difficult for them to participate in the study
3) Patients with a history of claustrophobia or fear of the dark, who are deemed to have difficulty participating in MRI imaging
4) Patients with metal in the body (for MRI imaging).
5) Pregnant women.

Translated with www.DeepL.com/Translator (free version)

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yuichi
Middle name
Last name Ogino

Organization

Gunma University Hospital

Division name

Anesthesiology

Zip code

371-8511

Address

3-39-15 Showa-machi, Maebashi-shi

TEL

0272208454

Email

oginoyuichi@me.com


Public contact

Name of contact person

1st name Yuichi
Middle name
Last name Ogino

Organization

Gunma University Hospital

Division name

Anesthesiology

Zip code

371-8511

Address

3-39-15 Showa-machi, Maebashi-shi

TEL

0272208454

Homepage URL


Email

oginoyuichi@me.com


Sponsor or person

Institute

SHIZUOKA CITY SHIMIZU HOSPITAL

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

SHIZUOKA CITY SHIMIZU HOSPITAL

Address

1231 Miyakami, Shimizu-ku, Shizuoka-shi

Tel

0543361111

Email

oginoyuichi@me.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

静岡市立清水病院


Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 03 Month 18 Day

Date of IRB

2022 Year 03 Month 18 Day

Anticipated trial start date

2022 Year 03 Month 18 Day

Last follow-up date

2023 Year 07 Month 31 Day

Date of closure to data entry

2026 Year 03 Month 31 Day

Date trial data considered complete

2026 Year 03 Month 31 Day

Date analysis concluded

2026 Year 03 Month 31 Day


Other

Other related information

observational study


Management information

Registered date

2022 Year 04 Month 13 Day

Last modified on

2023 Year 08 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054144


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name